This topic contains a solution. Click here to go to the answer

Author Question: Researchers who want to induce a mild, temporary form of depression in research participants often ... (Read 67 times)

torybrooks

  • Hero Member
  • *****
  • Posts: 500
Researchers who want to induce a mild, temporary form of depression in research participants often have those participants read a series of depressing statements.

Question 2

When researchers try to induce mild, temporary depression in participants, they often have the participants recite depressing statements. This strategy is often successful, but in some cases these people act differently than truly depressed people.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Ptupou85

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1



Answer to Question 2





torybrooks

  • Member
  • Posts: 500
Reply 2 on: Jun 20, 2018
Thanks for the timely response, appreciate it


kishoreddi

  • Member
  • Posts: 329
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Thyroid conditions cause a higher risk of fibromyalgia and chronic fatigue syndrome.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Illness; diuretics; laxative abuse; hot weather; exercise; sweating; caffeine; alcoholic beverages; starvation diets; inadequate carbohydrate consumption; and diets high in protein, salt, or fiber can cause people to become dehydrated.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library